Clinical ProgressThe company's ongoing clinical advancements, notably with the P3 study of Ovaprene, demonstrates continuous progress in its development pipeline.
Commercial PartnershipsThe successful US launch of Xaciato and the receipt of a substantial commercial milestone payment underscore the company's strong commercial partnerships.
Regulatory MilestonesThe positive feedback from the FDA regarding the sildenafil cream indicates significant potential for meeting the needs of a broad patient population.